Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-04
2006-07-04
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000, C544S129000, C544S130000, C544S360000, C514S253110
Reexamination Certificate
active
07071191
ABSTRACT:
Substituted non-imidazole aryloxypiperidine compounds, compositions containing them, and methods of making and using them to treat or prevent histamine-mediated conditions.
REFERENCES:
patent: 5182291 (1993-01-01), Gubin
patent: 5352707 (1994-10-01), Pompni
patent: 5580883 (1996-12-01), Goto et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 5929089 (1999-07-01), Jegham et al.
patent: 0 978 512 (2000-02-01), None
patent: 0 982 300 (2000-03-01), None
patent: 0 982 300 (2000-03-01), None
patent: WO 93/20061 (1993-10-01), None
patent: WO 95/14007 (1995-05-01), None
patent: WO 97/17345 (1997-05-01), None
patent: WO 99/42458 (1999-08-01), None
patent: WO 00/06254 (2000-02-01), None
Greene Protective Groups in Organic Synthesis ((1981).
PCT International Search Report PCT/US01/24660 dated Apr. 18, 2002.
Ganellin, C.R. et al.; “Synthesis of Potent Non-imidazole Histamine H3-Receptor Antagonists”; Arch. Pharm. Pharm. Med. Chem. (Weinheim, Ger.); 1998 331:395-404.
Meier, G. et al.; “Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonists”; Eur. J. Pharm. Sci.; 2001 13:249-259.
Walczynski, K. et al, “Non-Imidazole Histamine H3 Ligands, Part 2: New 2-Substituted Benzothiazoles as Histamine H3 Antagonists”; Arch. Pharm. Pharm. Med. Chem. (Weinheim, Ger.); 1999 332:389-398.
Walczynski, K. et al. “Non-Imidazole Histamine H3 Ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole Derivatives as H3-Antagonists with H1 Blocking Activities”; IL Farmaco; 1999 54:684-694.
Ganellin, C. Robin, et al.: “Synthesis of Potent Non-imidazole Histamine H3-Receptor antaonists”; Archiv Der Pharmazie., 1998, pp. 395-404, vol. 331, XP002123596 VCH Verlagsgesellschaft MGH, Weinhelm, DE ISSN; 0365-06233.
Stark, H., et al.: “General Construction Pattern of Histamine H3-Receptor Antaonists: Change of a paradigm” Bioorganic & Medicinal Chemistry Letters, 1998, pp. 2011-2016, No. 8, XP004137177 Oxford, GB ISSN: 0960-894X.
Apodaca Richard
Carruthers Nicholas I.
Dvorak Curt A.
Shah Chandravadan R.
Xiao Wei
Harbour John
Lopez Gabriel
Ortho-McNeil Pharmaceutical , Inc.
Shameem Golam M M
LandOfFree
Non-imidazole aryloxypiperidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-imidazole aryloxypiperidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-imidazole aryloxypiperidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3548239